Bill Ackman was not having a good year thus far, but things are certainly looking up for the silver-haired investor.
The head of Pershing Square Capital Management just made $113.4 million back when Valeant shares surged earlier this week.
The pharmaceutical giant received unsolicited offers for its core assets. Traders reacted by buying up the stock, boosting the stock by 23%.
Pershing 22.6 million shares of Valeant and is the company’s largest shareholder.